Yang et al., reported that ABC294640, the SphK2 inhibitor, sensitized TRAIL-induced NSCLC cell apoptosis possibly through upregulating death receptor4/5 (DR4/5) [17]. This evidence concerns the gene SPHK2 and non-small cell lung carcinoma.